Skip to main content

PEAK6 LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1389958 AUSTIN, TX

Position in ALNY

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,214,732
+$3,213,937 QoQ
Shares Held
9,716
+485700.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Derivatives in ALNY

reported options exposure · as of Mar 31, 2026
CallValue
$330,870
CallShares
1,000
PutValue
$3,176,352
PutShares
9,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PEAK6 LLC holds $24,388,144 across 19 Biotechnology names. ALNY ranks #3 (13.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page
9,716 $3,214,732

All Filings in ALNY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $330,870 1,000
2026-03-31 $3,176,352 9,600
2026-03-31 $3,214,732 9,716
2025-12-31 $20,160,855 50,700
2025-12-31 $795 2
2025-09-30 $23,620,800 51,800
2025-09-30 $319,200 700
2025-09-30 $1,368 3
2025-06-30 $423,917 1,300
2025-06-30 $10,793,579 33,100
2025-03-31 $3,591,266 13,300
2025-03-31 $27,002 100
2025-03-31 $619,695 2,295
2024-12-31 $2,518,287 10,702
2024-12-31 $11,224,287 47,700